Loading…
Lobbying Spend
—
Filings
20
Firms Hired
2
Active Period
2023–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Medicaid VBPs for Patients Act
2024 · fourth_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666); Creating Hope Reauthorization Act (H.R. 7384 / S. 4583); Patient Access Act (H.R. 9184)
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2666
Medicaid VBPs for Patients Act
2024 · fourth_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666); Creating Hope Reauthorization Act (H.R. 7384 / S. 4583); Patient Access Act (H.R. 9184)
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2666
Creating Hope Reauthorization Act of 2024
2024 · fourth_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666); Creating Hope Reauthorization Act (H.R. 7384 / S. 4583); Patient Access Act (H.R. 9184)
Client expense: — · Firm income: $60,000
Matched citations: H.R. 7384
Creating Hope Reauthorization Act of 2024
2024 · fourth_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666); Creating Hope Reauthorization Act (H.R. 7384 / S. 4583); Patient Access Act (H.R. 9184)
Client expense: — · Firm income: $60,000
Matched citations: H.R. 7384
Patient Access Act of 2024
2024 · fourth_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666); Creating Hope Reauthorization Act (H.R. 7384 / S. 4583); Patient Access Act (H.R. 9184)
Client expense: — · Firm income: $60,000
Matched citations: H.R. 9184
Patient Access Act of 2024
2024 · fourth_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666); Creating Hope Reauthorization Act (H.R. 7384 / S. 4583); Patient Access Act (H.R. 9184)
Client expense: — · Firm income: $60,000
Matched citations: H.R. 9184
Creating Hope Reauthorization Act of 2024
2024 · fourth_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666); Creating Hope Reauthorization Act (H.R. 7384 / S. 4583); Patient Access Act (H.R. 9184)
Client expense: — · Firm income: $60,000
Matched citations: S. 4583
Creating Hope Reauthorization Act of 2024
2024 · fourth_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666); Creating Hope Reauthorization Act (H.R. 7384 / S. 4583); Patient Access Act (H.R. 9184)
Client expense: — · Firm income: $60,000
Matched citations: S. 4583
Medicaid VBPs for Patients Act
2024 · third_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666); Creating Hope Reauthorization Act (H.R. 7384 / S. 4583); Patient Access Act (H.R. 9184)
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2666
Medicaid VBPs for Patients Act
2024 · third_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666); Creating Hope Reauthorization Act (H.R. 7384 / S. 4583); Patient Access Act (H.R. 9184)
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2666
Creating Hope Reauthorization Act of 2024
2024 · third_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666); Creating Hope Reauthorization Act (H.R. 7384 / S. 4583); Patient Access Act (H.R. 9184)
Client expense: — · Firm income: $60,000
Matched citations: H.R. 7384
Creating Hope Reauthorization Act of 2024
2024 · third_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666); Creating Hope Reauthorization Act (H.R. 7384 / S. 4583); Patient Access Act (H.R. 9184)
Client expense: — · Firm income: $60,000
Matched citations: H.R. 7384
Patient Access Act of 2024
2024 · third_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666); Creating Hope Reauthorization Act (H.R. 7384 / S. 4583); Patient Access Act (H.R. 9184)
Client expense: — · Firm income: $60,000
Matched citations: H.R. 9184
Patient Access Act of 2024
2024 · third_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666); Creating Hope Reauthorization Act (H.R. 7384 / S. 4583); Patient Access Act (H.R. 9184)
Client expense: — · Firm income: $60,000
Matched citations: H.R. 9184
Creating Hope Reauthorization Act of 2024
2024 · third_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666); Creating Hope Reauthorization Act (H.R. 7384 / S. 4583); Patient Access Act (H.R. 9184)
Client expense: — · Firm income: $60,000
Matched citations: S. 4583
Creating Hope Reauthorization Act of 2024
2024 · third_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666); Creating Hope Reauthorization Act (H.R. 7384 / S. 4583); Patient Access Act (H.R. 9184)
Client expense: — · Firm income: $60,000
Matched citations: S. 4583
Medicaid VBPs for Patients Act
2024 · second_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666); Creating Hope Reauthorization Act (H.R. 7384 / S. 4583); Legislation related to antikickback exclusions for travel and lodging arrangements between manufacturers of drugs and patients
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2666
Medicaid VBPs for Patients Act
2024 · second_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666); Creating Hope Reauthorization Act (H.R. 7384 / S. 4583); Legislation related to antikickback exclusions for travel and lodging arrangements between manufacturers of drugs and patients
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2666
Creating Hope Reauthorization Act of 2024
2024 · second_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666); Creating Hope Reauthorization Act (H.R. 7384 / S. 4583); Legislation related to antikickback exclusions for travel and lodging arrangements between manufacturers of drugs and patients
Client expense: — · Firm income: $60,000
Matched citations: H.R. 7384
Creating Hope Reauthorization Act of 2024
2024 · second_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666); Creating Hope Reauthorization Act (H.R. 7384 / S. 4583); Legislation related to antikickback exclusions for travel and lodging arrangements between manufacturers of drugs and patients
Client expense: — · Firm income: $60,000
Matched citations: H.R. 7384
Creating Hope Reauthorization Act of 2024
2024 · second_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666); Creating Hope Reauthorization Act (H.R. 7384 / S. 4583); Legislation related to antikickback exclusions for travel and lodging arrangements between manufacturers of drugs and patients
Client expense: — · Firm income: $60,000
Matched citations: S. 4583
Creating Hope Reauthorization Act of 2024
2024 · second_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666); Creating Hope Reauthorization Act (H.R. 7384 / S. 4583); Legislation related to antikickback exclusions for travel and lodging arrangements between manufacturers of drugs and patients
Client expense: — · Firm income: $60,000
Matched citations: S. 4583
Medicaid VBPs for Patients Act
2024 · first_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666).
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2666
Medicaid VBPs for Patients Act
2024 · first_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666).
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2666
Medicaid VBPs for Patients Act
2023 · fourth_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666).
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2666
Source: Senate LDA